COVID-19 Webinar: Debating the Road Back to School


Join us tomorrow for an informative discussion on CDC guidance and insights from medical experts on navigating a way back to in-school learning.

coronavirus webinar

An original version of this article appeared on sister publication Contagion.

August traditionally kicks off back-to-school time in the United States, but this year presents challenges as the number of new, confirmed coronavirus cases increases each day in many parts of the country. Individual school districts and colleges debate the merits of in-school learning and weighing it with safety concerns.

School administrators, nurses and teachers are trying to develop plans to bring students back for in-school learning and try to keep everyone safe.

As everyone is still trying to navigate uncharted waters with highest stakes, MJH Life Sciences™ has created a webinar "Debating the Road Back to School," scheduled for this Thursday, August 20, at 6PM EDT.

This one-hour live event with our panel of experts will discuss current US Centers for Disease Control and Prevention guidance, outline what a safe return-to-school plan looks like, talk pros and cons of adding COVID-19 to the list of state-mandated immunizations for children once a vaccine is available, and share advice on how to counsel parents through this confusing time.

This webinar will feature the top minds in the field including:

  • Moderator: Kathleen Kenny, PharmD
  • Panelist: Donna Hallas, PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN
  • Panelist: Paul Lipkin, MD

Kenny is president and CEO of Med Ink Exec, LLC. With over 20 years of clinical training and experience, Kenny believes that well-educated patients and knowledgeable practitioners both contribute to improved health outcomes.

Hallas is a clinical professor and director of the Pediatrics NP Program at New York University Meyers College of Nursing. She has presented nationally and internationally on her research that focuses on improving healthcare outcomes for vulnerable children in the pediatric populations. Her current research is on Vaccine Hesitancy and Vaccine Resistance in prenatal women and mothers of young children.

Lipkin is an associate professor of pediatrics at the Kennedy Krieger Institute (KKI) and the Johns Hopkins School of Medicine, as well as KKI’s director of Outpatient Medical Services. Dr. Lipkin’s clinical and research careers have focused on the early identification, evaluation, and treatment of children and adolescents with developmental disabilities, including autism, learning, and attention disorders.

Attendees can ask our panel questions during the webinar.

Don’t miss out on this must-attend event! Sign up here.

Related Videos
Addressing HS Risks at the Genetic Level, with Kai Li, BSc
Maternal Hidradenitits Suppurativa Linked to Neonatal Mortality, Pediatric Hospitalization Risk
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
Reviewing 2023 with FDA Commissioner Robert M. Califf, MD
A Year of RSV Highs and Lows, with Tina Tan, MD
Gestational Low-Dose Aspirin Does Not Increase Risk of IBD Flares in Women
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Riha Bhatt, MD: Mimickers and Concurrent Diseases in Pediatric IBD
Elizabeth Spencer, MD: Precision Medicine in Pediatric IBD
Anita Clayton, MD: Zuranolone for Postpartum Depression
© 2024 MJH Life Sciences

All rights reserved.